Neuronetics appointed Nir Naor as Executive Vice President, Chief Financial Officer, and Treasurer, effective July 23, 2026. Naor brings over two decades of finance experience in the life sciences sector. He previously served as CFO at Axogen, Arbor Pharmaceuticals, and Mölnlycke. At Axogen, he helped the company achieve profitability and positive cash flow.
The appointment marks a broader leadership transition for the medical technology company. Andrew Macan, Executive Vice President and Chief Legal Officer, will step down on August 15, 2026. The company also promoted Cory Anderson to Executive Vice President and General Manager of Greenbrook, its network of psychiatry clinics.